Download PDF
Thromb Haemost 2012; 108(04): 798-800
DOI: 10.1160/TH12-05-0322
Letters to the Editor
Schattauer GmbH

Haemorrhage due to proteolysis of FXIII and hyperfibrinolysis under vemurafenib treatment of metastatic melanoma

Ralf Trappe
1   Department of Internal Medicine II: Haematology and Oncology, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany
,
Ulrich Budde
2   Medilys Laborgesellschaft mbH, Hamburg, Germany
,
Heiner Zimmermann
1   Department of Internal Medicine II: Haematology and Oncology, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany
› Author Affiliations
Further Information

Publication History

Received: 16 May 2012

Accepted after major revision: 01 August 2012

Publication Date:
29 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Chapman PB, Hauschild A, Robert C. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507-2516.
    CrossrefPubMedGoogle Scholar
  • 2 Taylor Jr FB, Toh CH, Hoots WK. et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-1330.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Dombret H, Scrobohaci ML, Ghorra P. et al. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. Leukemia 1993; 07: 2-9.
    PubMedGoogle Scholar
  • 4 Susens G P, Hendrickson C, Barto DA. et al. Letter: Disseminated intravascular coagulation syndrome with metastatic melanoma: Remission after treatment with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC). Ann Intern Med 1976; 84: 175-176.
    CrossrefPubMedGoogle Scholar
  • 5 Schlaeppi MR, Korte W, von Moos R. et al. Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma. Onkologie 2006; 29: 531-533.
    PubMedGoogle Scholar
  • 6 Takada K, Kato J, Kawano Y. et al. Effective CDDP arterial infusion with DSM for liver metastasis of malignant melanoma complicating DIC due to intratumoral hemorrhage--a case report. Gan To Kagaku Ryoho 2008; 35: 1803-1805.
    PubMedGoogle Scholar
  • 7 Lepelley-Dupont C, Meyer N, Lesimple T. et al. Melanoma-associated disseminated intravascular coagulation. J Eur Acad Dermatol Venereol 2009; 23: 720-721.
    CrossrefPubMedGoogle Scholar
  • 8 Delyon J, Mateus C, Lambert T. Hemophilia A induced by ipilimumab. N Engl J Med 2011; 365: 1747-1748.
    CrossrefPubMedGoogle Scholar
  • 9 EMA CHMP Assessment report Zelboraf [Internet]. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002409/WC500124400.pdf Accessed Apr 13, 2012..
    PubMed
  • 10 Klingemann HG, Egbring R, Holst F. et al. Degradation of human plasma fibrin stabilizing factor XIII subunits by human granulocytic proteinases. Thromb Res 1982; 28: 793-801.
    CrossrefPubMedGoogle Scholar
  • 11 Bagoly Z, Haramura G, Muszbek L. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot. Thromb Haemost 2007; 98: 359-367.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Hofmann UB, Westphal JR, Van Muijen GN. et al. Matrix metalloproteinases in human melanoma. J Invest Dermatol 2000; 115: 337-344.
    CrossrefPubMedGoogle Scholar
  • 13 Dempfle C-E. Bestimmung des D-Dimer-Antigens in der klinischen Routine. Dtsch Arztebl 2005; 102: A428-432.
    PubMedGoogle Scholar